S. Lahore et al. / Tetrahedron Letters xxx (2014) xxx–xxx
3
Table 1
structure–activity information inferred from our study could pro-
vide a basis for rational design of new structurally simple anti-
fungal agents and the starting point for their optimization.
Antifungal activity of farinomaleins
Compounds
Antifungal activitya
(lg) C. cladosporioides
1
2
3
4
21a
21b
21c
21d
5
0.5
20
20
50
50
30
50
0.1
References and notes
5. Preparation of farinomalein C. To a stirred solution of farinomalein A (0.1 g,
0.47 mmol) in DCM (5 mL) DMAP (0.86 g, 0.70 mmol) was added and the
mixture was stirred at room temperature under nitrogen for 10 min. After
addition of DCC (0.146 g, 0.70 mmol) stirring was continued for further 30 min
at room temperature, then 1-butanol (0.053 g, 0.70 mmol) was added at 10 °C.
The reaction mixture was stirred at room temperature overnight, then it was
filtered through cotton and purified by column chromatography (ethyl acetate/
hexane 2:8) to give farinomalein C (0.117 g, 92%). Rf = 0.6 (ethyl acetate/hexane
50:50). The spectroscopic data of the compound matched with those reported
in the literature.2
Prochloraz
a
Minimum amount required for the inhibition of fungal growth on thin-layer
chromatography plates (TLC).
O
R
H
N
O
6. Preparation of 3-(3-isopropyl-2,5-dioxo-2,5-dihydro-pyrrol-1-yl)-propionic acid
2,2-dimethyl-1,3]dioxolan-4-ylmethyl ester (10). To
farinomalein A (0.2 g, 0.94 mmol) in DCM (10 mL), DCC (0.292 g, 1.4 mmol),
DMAP (0.172 g, 1.5 mmol) and (S)-isopropylideneglycerol (0.187 g,
a stirred solution of
O
HO
9
21a R = H
1.5 mmol) were added at 0 °C. The resulting mixture was stirred at room
temperature overnight under nitrogen, then it was filtered through cotton and
purified by column chromatography (ethyl acetate/hexane 2:8) to give the title
compound (0.236 g, 77%). Rf = 0.4 (ethyl acetate/hexane 3:7). [a]D25 +1.3 (c 1.0,
MeOH). 1H NMR (300 MHz, CDCl3) d 6.22 (1H, s); 4.30 (1H, m); 4.19–4.02 (3H,
m); 3.80 (2H, t, J = 7.3 Hz); 3.73 (1H, m); 2.82 (1H, m); 2.66 (2H, t, J = 7.3 Hz);
1.42 (3H, s); 1.35 (3H, s); 1.20 (6H, d, J = 6.7 Hz). 13C NMR (300 MHz, CDCl3) d
170.4, 170.2, 170.0, 155.5, 124.2, 109.4, 73.0, 65.9, 64.7, 33.1, 32.5, 26.3, 25.4,
21b R = CH(CH3)2
21c R = CH2CH(CH3)2
21d R = CH2Ph
Figure 2. Structures of farinomalein A analogues.
The results confirmed that farinomalein A is endowed with
antifungal activity on this pathogen, the minimum amount
required for the inhibition of fungal growth on thin-layer chroma-
tography (TLC) plates being 5
showed a ten-fold increased potency, inhibiting the fungal growth
at 0.5 g. Farinomalein E and (R)-/(S)-/racemic farinomaleins D all
showed a lower activity (20 g), thus confirming that the stereo-
chemistry did not affect the antifungal activity (Table 1).
To depict preliminary structure–activity relationships for this
class of compounds, the results were compared to those obtained
testing a series of farinomalein A derivatives previously prepared
by our group4 (compounds 21a–d, Fig. 2).
The minimum amount of compounds 21a–d required for fungal
growth inhibition was 6 to 10-fold larger than for 1 (30–50 lg)
(Table 1).
The results clearly indicate that the introduction of different
chains to the carboxylic group, or the esterification with polar
8. Preparation of (R)-farinomalein D. (3) A solution of compound 10 (0.158 g) in
AcOH/H2O (4:1, v/v; 4.66 mL) was stirred at 50 °C (bath temperature) for 3 h.
The heating bath was removed, and saturated aqueous NaHCO3 (10 mL) was
added. The mixture was extracted with ethyl acetate (3 ꢁ 20 mL). The
combined organic extracts were washed with brine and dried with
anhydrous sodium sulfate. The solvent was removed under reduced pressure
and the residue was purified by flash chromatography on silica gel (ethyl
acetate) to obtain the title compound (70%). Rf = 0.35 (ethyl acetate/hexane
50:50). [a]2D5 ꢀ7.2 (c 1.0, MeOH). The spectroscopic data of the compound
matched with those reported in the literature.2
13. Farinomalein E. To a stirred solution of farinomalein A (0.2 g, 0.94 mmol) in
DCM (3 mL) DMAP (0.115 g, 0.94 mmol) was added and the solution was
stirred at room temperature under nitrogen for 10 min. After addition of
EDCIꢂHCl (0.181 g, 0.94 mmol), the solution was stirred at room temperature
for further 30 min, then 20 (0.123 g, 0.94 mmol) dissolved in 2 mL DCM was
added at 10 °C. The reaction mixture was stirred at room temperature
overnight. Purification by column chromatography (ethyl acetate/hexane
3:7) gave farinomalein E (0.132 g, 42%). Rf = 0.5 (ethyl acetate/hexane 1:1).
The spectroscopic data of the compound matched with those reported in the
literature.2
lg. Interestingly, farinomalein C
l
l
a
moieties, was detrimental for activity. Conversely, a lipophilic
chain as in farinomalein C led to an increase of activity, comparable
with that of the reference compound prochloraz. These data con-
firm that farinomaleins can be considered promising candidates
in the field of antifungal compounds.
Current efforts are directed towards the synthesis of new ana-
logues. Notwithstanding the fact that the molecular mechanism
of action of the reported compounds remains to be defined,